O'Grady Brendan P.

CEO | EVP, North America Commercial

2 companies

O'Grady Brendan P. is a CEO at Assertio Holdings, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 14 sells.

Estimated insider holdings value: $3.4M based on current market prices.

Holdings by Company

ASRTMay 31, 2025

Current Shares129.0K

Value$2.90M

Net Activity+11.7K

Bought: 11.7KSold: 0

TEVAMar 5, 2021

Current Shares14.9K

Value$530.7K

Net Activity-142,149

Bought: 0Sold: 142.1K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 14, 2024	ASRT Assertio Holdings, Inc.	CEO	Buy	11,706	$0.85	$9,950.49	New	+2.5%	-6.0%
Mar 5, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	19,608	$10.56	$207,090.64	-25.9%	-	-
Mar 3, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	15,548	$10.85	$168,630.73	-33.8%	-	-
Mar 1, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	73,127	$10.91	$798,022.67	-37.3%	-	-
Feb 9, 2021	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	20,694	$12.69	$262,699.98	-10.7%	-	-
Mar 17, 2020	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	470	$7.16	$3,366.85	-3.1%	-	-
Mar 3, 2020	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	463	$11.37	$5,262.37	-3.2%	-	-
Feb 10, 2020	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	4,799	$12.27	$58,883.73	-26.3%	-	-
Sep 18, 2019	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	494	$7.83	$3,868.66	-18.8%	-	-
Mar 18, 2019	TEVA Teva Pharmaceutical Industries Ltd	EVP, North America Commercial	Sale+OE	1,179	$16.63	$19,600.99	-45.9%	-	-